Cargando…

Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

Detalles Bibliográficos
Autores principales:	Rosell, Rafael, Filipska, Martyna, Chaib, Imane, Lligé, David, Laguia, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511626/ https://www.ncbi.nlm.nih.gov/pubmed/33014853 http://dx.doi.org/10.3389/fonc.2020.01726

Ejemplares similares

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment
por: Filipska, Martyna, et al.
Publicado: (2021)

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
por: Santarpia, Mariacarmela, et al.
Publicado: (2020)

CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy
por: Elmas, Ezgi, et al.
Publicado: (2022)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC)
por: Bracht, Jillian Wilhelmina Paulina, et al.
Publicado: (2019)

Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma
por: Ito, Masaoki, et al.
Publicado: (2019)

Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT Screening
por: Rosell, Rafael, et al.
Publicado: (2015)

CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma
por: Guo, Yelei, et al.
Publicado: (2022)

CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
por: Lu, Tongyi, et al.
Publicado: (2020)

Commentary: CRISPR gene editing for inherited retinal dystrophies: Towards clinical translation
por: Bansal, Mayank, et al.
Publicado: (2022)

Safety and feasibility of robotic-assisted thoracic surgery after neoadjuvant chemoimmunotherapy in non-small cell lung cancer
por: Zeng, Jun, et al.
Publicado: (2023)

Demystification and feasibility of CRISPR technology and gene editing in African laboratories
por: Jemaà, Mohamed
Publicado: (2023)

Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
Publicado: (2021)

Erratum: Safety and feasibility of robotic-assisted thoracic surgery after neoadjuvant chemoimmunotherapy in non-small cell lung cancer
Publicado: (2023)

A commentary on (125)I seed brachytherapy for refractory loco-regional recurrence of non-anaplastic thyroid cancer
por: Wang, Yamei, et al.
Publicado: (2022)

Selecting for CRISPR-Edited Knock-In Cells
por: Reuven, Nina, et al.
Publicado: (2022)

Commentary: Molecular Machines Open Cell Membranes
por: Patil, Shankargouda, et al.
Publicado: (2017)

The use of plant-derived exosome-like nanoparticles as a delivery system of CRISPR/Cas9-based therapeutics for editing long non-coding RNAs in cancer colon cells
por: Hillman, Tatiana
Publicado: (2023)

Efficacy and Safety of Lenalidomide Monotherapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis
por: Li, Jia, et al.
Publicado: (2021)

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer
por: Zhao, Ziran, et al.
Publicado: (2023)

Genotyping MUltiplexed-Sequencing of CRISPR-Localized Editing (GMUSCLE): An Experimental and Computational Approach for Analyzing CRISPR-Edited Cells
por: Zhang, Peng, et al.
Publicado: (2023)

Feasibility and safety of expandable mediastinoscopic and laparoscopic radical esophagectomy
por: Zhang, Weidong, et al.
Publicado: (2023)

Commentary: Induction of Dormancy in Hypoxic Human Papillomavirus-Positive Cancer Cells
por: Szalmás, Anita
Publicado: (2018)

A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects
por: Wang, Heming, et al.
Publicado: (2021)

Feasibility of Tomotherapy-Based Image-Guided Radiotherapy for Small Cell Lung Cancer
por: Nguyen, Nam P., et al.
Publicado: (2013)

Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapy
por: Dibs, Khaled, et al.
Publicado: (2022)

The Rise of CRISPR/Cas for Genome Editing in Stem Cells
por: Shui, Bing, et al.
Publicado: (2016)

Challenges of CRISPR-Based Gene Editing in Primary T Cells
por: Rezalotfi, Alaleh, et al.
Publicado: (2022)

Efficacy and safety of CalliSpheres drug-eluting beads for bronchial arterial chemoembolization for refractory non-small-cell lung cancer and its impact on quality of life: A multicenter prospective study
por: Zhao, Yu Wei, et al.
Publicado: (2023)

Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer
por: Xu, Yangyang, et al.
Publicado: (2022)

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)
por: Codony-Servat, Carles, et al.
Publicado: (2017)

Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer
por: Elsayed, Mei, et al.
Publicado: (2021)

CRISPR/Cas9(-3NLS)/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression
por: Wu, Zhouying, et al.
Publicado: (2022)

Commentary: The Incidence of Node-Positive Non-small-Cell Lung Cancer Undergoing Sublobar Resection and the Role of Radiation in Its Management
por: Veronesi, Giulia
Publicado: (2020)

Src-Homology 2 Domain-Containing Phosphatase 2 in Resected EGFR Mutation-Positive Lung Adenocarcinoma
por: Ito, Masaoki, et al.
Publicado: (2020)

Comparison of the Feasibility, Efficiency, and Safety of Genome Editing Technologies
por: González Castro, Nicolás, et al.
Publicado: (2021)

Commentary: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
por: Temiz, Mustafa Zafer
Publicado: (2021)

Flatland: an edition with notes and commentary
por: Abbott, Edwin A, et al.
Publicado: (2010)

Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative
por: Snee, Michael, et al.
Publicado: (2021)

Safety and Feasibility of Microwave Ablation for Hepatocellular Carcinomas in the Elderly: A Systematic Review
por: Liang, Weiren, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s0fk5smtovcetgvrmed24va5gf